Claudio Tondo, Corrado
Carbucicchio, Stefania Riva, Gaetano Fassini, Paolo Della Bella.
Institute of Cardiology, University of Milan, CNR, Centro Cardiologico Fondazione Monzino,
IRCCS, Milan, Italy
|
|
In the most recent years, radiofrequency catheter
ablation (RFCA) has become an alternative therapeutical approach for treating post
myocardial (MI) recurrent drug refractory ventricular tachycardia (VT). The acute success
rate, in the most experienced laboratories, ranges from 70% to 75%1
with recurrence rate of the same clinical VT in over 20% of patients during the follow-up.
Although these results are encouraging, especially because related to patients presenting
with monomorphic, haemodynamically tolerated VTs, therefore allowing extensive, accurate
mapping, there is still a proportion of patients with rapid and/or multiple VT
morphologies who do not currently benefit from RFCA. Potential reasons for this include a
more complex substrate not entirely identified by currently accepted endocardial mapping
criteria, or insufficient lesion created by conventional RF current delivery in those
cases in which an epicardial origin of VT is suspected. Accurate mapping along with pacing
maneuvers are mandatory to identify the critical area of the reentry circuit, that is the
area of slow conduction, a desirable goal for ablation2.
In order to better characterize the reentry circuit in post-MI VT, and therefore for
identifying successful ablation sites, we have recently introduced, as standard procedure,
a multisite epicardial recording in conjunction with conventional endocardial mapping in
patients with recurrent post-MI VT3. However, for the
specific purpose of this study, we focus our attention on those patients with pleomorphic
haemodynamically unstable VTs undergoing RFCA, and their relationship with findings
obtained from multisite epicardial mapping. In a population of 56 patients, RFCA was not
performed in 7 patients because of induction of multiple3-8,
fast, untolerated VTs, leading to internal automatic cardioverter defibrillator (AICD)
implant. During the follow-up, AICD discharge was documented in 5 patients. In the effort
to elucidate the electrophysiologic substrate of these patients, the results of the
epicardial mapping performed in 16 patients with post-MI VT were retrospectively analyzed.
|